insights_auto
Kwa nini M1RN34 imepungua kwa 7.72%?
Fahamu zaidichevron_right
M1RN34:BVMF
Moderna Inc Bdr
R$ 46.65
arrow_downward
-7.72%(-3.90) Siku 1
6 Okt, 17:06:00 GMT -3 · BRL
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya M1RN34...
Fungua
R$ 50.54
Juu
R$ 52.60
Chini
R$ 46.64
Mtaji wa soko
69.98B
Wastani wa kiasi cha mauzo
elfu 115.33
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 54.38
Chini kwa wiki 52
R$ 6.02
Hisa za wawekezaji
399.24M
Idadi ya wafanyakazi
elfu 5
Fungua
R$ 50.54
Juu
R$ 52.60
Chini
R$ 46.64
Mtaji wa soko
69.98B
Wastani wa kiasi cha mauzo
elfu 115.33
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
R$ 54.38
Chini kwa wiki 52
R$ 6.02
Hisa za wawekezaji
399.24M
Idadi ya wafanyakazi
elfu 5
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Investor's Business Daily
·
saa 7 zilizopita
Biotechs Sell Off — These Are The Biggest Losers
Investing.com
·
saa 9 zilizopita
Why is Moderna stock sliding today?
TipRanks
·
saa 9 zilizopita
Why Is Moderna Stock (MRNA) Falling Today, October 6?
Kalkine Media
·
saa 10 zilizopita
What Does Joining the Nasdaq Mean for Moderna (NASDAQ:MRNA) Shares?
Wasifu
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Kuhusu Moderna Inc Bdr
Afisa Mkuu Mtendaji (CEO)Stéphane Bancel
Wafanyakazielfu 4.7
LilianzishwaSep 2010
Makao makuu-
Sekta-
Tovutimodernatx.com